Company intelligence / Profile preview

Clue

Hillsborough, North Carolina, USAhelloclue.com ↗

Ownership: Private
Development stage: Commercial

Overview

Clue Genetics leverages proprietary genomics/bioinformatics to mine large libraries of fungal/microbial genomes for novel natural products with therapeutic potential. It recently acquired a unique collection of 50,000+ fungal strains to expand its discovery capabilities. No clinical results reported yet; focus remains on early-stage R&D.

Therapeutic areas: OncologyInfectious DiseasesOther
Modalities: Small molecule (natural products derived from fungi and microbes)Enzyme (biocatalysts from microbial sources)Biologic (microbial/fungal-derived compounds)
Industry: Biotech

Beyond the preview

Go deeper on Clue.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Clue.

Explore the full profile